Medipharm Labs Corp (LABS : TSX)
Common Stock
$0.07
CAD
-0.01 (-6.25%)
Last updated: 2026-06-03
LABS
Medipharm Labs Corp
WealthAwesomePerformance
1 Day
-6.25%
1 Week
-6.25%
1 Month
-11.76%
YTD
+7.14%
Key Statistics
Market Cap
$33.99M
52W High
$0.10
52W Low
$0.06
P/E Ratio
-
50 Day MA
$0.07
200 Day MA
$0.07
Beta
0.96
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/3/2026 | $0.08 | $0.08 | $0.07 | $0.07 | $0.07 | 135,070 |
| 6/2/2026 | $0.08 | $0.08 | $0.07 | $0.08 | $0.08 | 42,225 |
| 6/1/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 39,569 |
| 5/29/2026 | $0.07 | $0.07 | $0.07 | $0.07 | $0.07 | 428,751 |
| 5/28/2026 | $0.08 | $0.08 | $0.07 | $0.07 | $0.07 | 34,998 |
| 5/27/2026 | $0.07 | $0.08 | $0.07 | $0.08 | $0.08 | 157,811 |
| 5/26/2026 | $0.08 | $0.08 | $0.07 | $0.08 | $0.08 | 107,204 |
| 5/25/2026 | $0.08 | $0.09 | $0.07 | $0.08 | $0.08 | 336,283 |
| 5/22/2026 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 13,024 |
| 5/21/2026 | $0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 19,430 |
Analyst Price Targets
Based on analyst covering LABS
Wall Street analysts forecast LABS stock price to rise 33.3% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.10
+33.3% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LABS's historical volatility
30-Day Vol
98.1%
Annualized
90-Day Vol
84.1%
Annualized
Trend (90d)
+29.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.06 โ C$0.11 |
| 60 trading days | C$0.08 | C$0.05 โ C$0.13 |
| 90 trading days | C$0.08 | C$0.05 โ C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Medipharm Labs Corp
MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower, pre-roll, and other cannabis products. In addition, the company offers cannabis related medical information and services; and cannabis clinic services for patients requiring medical cannabis education and prescriptions. MediPharm Labs Corp. was founded in 2015 and is based in Barrie, Canada.
Financials
- Revenue (TTM)
- $43.28M
- EBITDA
- $-6.11M
- Profit Margin
- -20.21%
- ROE (TTM)
- -22.33%
- EPS (Diluted)
- -0.02
- Book Value
- 0.08
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report